Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

AMRXAMRX

Showing 6 of 18 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in AMNEAL PHARMACEUTICALS INC

No. Connor, Clark & Lunn Investment Management exited its AMRX (Amneal Pharmaceuticals) position in Q4 2025. Its Q3 2025 13F listed 623,258 shares worth $6.2M. Connor, Clark & Lunn Investment Management first reported AMRX in Q1 2020 and held it in 16 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4.6M

Total Shares Change

-548,975

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$12.60
0
2025-Q3
Increased
623,258
+3.5%
$6.2M0.0%$10.01
28
2025-Q2
Increased
602,468
+14.2%
$4.9M0.0%$8.09
31
2025-Q1
Decreased
527,685
-5.0%
$4.4M0.0%$8.38
0
2024-Q4
Increased
555,655
+1.2%
$4.4M0.0%$7.92
27
2024-Q3
Decreased
548,975
-1.6%
$4.6M0.0%$8.32
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used